Recruiting

Overdose PreventionA Setting Focus Overdose Prevention Intervention

Sponsor:

Johns Hopkins Bloomberg School of Public Health

Code:

NCT05320835

Conditions

HIV Infections

HCV

Drug Overdose

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

HIV, HCV and overdose prevention

Study Details

Brief summary:

A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).

Conditions

HIV Infections

HCV

Drug Overdose

Study ID

NCT05320835

Start date

Apr 30, 2022

Status verified date

May, 2026

Completion date

May 30, 2027

Anticipated

Primary completion date

Dec 1, 2026

Anticipated

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

Current drug user (opioid use in the prior two weeks)

Exclusion Criteria:

Any mental or physical health impairment that impedes ability to participate

Study Design

Enrollment

285 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Experimental

behavioral training with 6 sessions

active comparator: comparison

Attention control

Interventions

HIV, HCV and overdose prevention

Primary outcome measure

Overdose prevention [ Time Frame: 6 months ]
HIV/HCV prevention [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Carl Latkin, PhD

410-955-3972 carl.latkin@jhu.edu

Lauren Dayton, PhD

4105025368 ldayton2@jhu.edu

Locations

Lighthouse Studies at Peer Point

Recruiting

Baltimore, Maryland, United States, 21205

Contacts

Carl Latkin, PhD

410-502-5368 carl.latkin@jhu.edu

Melissa Davey-Rothwell, PhD

410-614-5854 mdavey1@jhu.edu

Principal Investigator:

Carl Latkin, PhD

More Information

Sponsor

Johns Hopkins Bloomberg School of Public Health

Last update posted

May 22, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Johns Hopkins Bloomberg School of Public Health on 2026-05-22.